Literature DB >> 14605293

Reversible posterior leukoencephalopathy in a patient with systemic sclerosis/systemic lupus erythematosus overlap syndrome.

Patrick F K Yong1, Sally M A Hamour, Aine Burns.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14605293     DOI： 10.1093/ndt/gfg347

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  7 in total

1.  Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy.

Authors:  A Ozkan; B Hakyemez; F Ozkalemkas; R Ali; V Ozkocaman; T Ozcelik; O Taskapilioglu; Y Altundal; A Tunali
Journal:  Neuroradiology       Date:  2006-09-16       Impact factor: 2.804

Review 2.  The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients.

Authors:  Tatjana Zekić; Mirjana Stanić Benić; Ronald Antulov; Igor Antončić; Srđan Novak
Journal:  Rheumatol Int       Date:  2017-10-17       Impact factor: 2.631

3.  Recurring posterior reversible encephalopathy syndrome in a patient with polymyositis/systemic sclerosis overlap syndrome triggered by scleroderma renal crisis.

Authors:  Masaki Kobatake; Naoto Ishimaru; Yohei Kanzawa; Hiroyuki Seto; Saori Kinami
Journal:  Eur J Rheumatol       Date:  2019-04-09

4.  COVID-19 and Posterior Reversible Encephalopathy Syndrome.

Authors:  Fabio Noro; Fernando de Mendonça Cardoso; Edson Marchiori
Journal:  Neurol Clin Pract       Date:  2021-04

5.  Posterior reversible encephalopathy syndrome in a patient with systemic lupus erythematosus/systemic sclerosis overlap syndrome.

Authors:  Juliana Gomez; Erik J Jhonston; Francisco Zevallos
Journal:  Case Rep Rheumatol       Date:  2014-11-20

Review 6.  Delayed onset of posterior reversible encephalopathy syndrome in a case of scleroderma renal crisis with maintenance hemodialysis: Case report and literature review.

Authors:  Ching-Yang Chen; Shin-Yuan Hung; Yi-Jer Lee; Yi-Chan Lin; Chu-Cheng Pai
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

7.  Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy.

Authors:  Jordi Gandini; Mario Manto; Nicolas Charette
Journal:  Front Neurol       Date:  2020-01-30       Impact factor: 4.003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.